← 產業報告目錄
Warfarin Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 123報告編號 APO-54b9179424
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Warfarin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Warfarin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Warfarin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Warfarin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Warfarin include Amneal Pharma, BRISTOL MYERS SQUIBB, Cipla (InvaGen), IPCA LABS LTD, Orion Corporation Orion Pharma, Taro Pharmaceutical Industries Ltd., TEVA (Barr, PLIVA), UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) and Zydus Pharmaceuticals (USA) Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Warfarin market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Warfarin Market by Company
Amneal Pharma
BRISTOL MYERS SQUIBB
Cipla (InvaGen)
IPCA LABS LTD
Orion Corporation Orion Pharma
Taro Pharmaceutical Industries Ltd.
TEVA (Barr, PLIVA)
UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
Zydus Pharmaceuticals (USA) Inc
Beijing Jialin Pharmaceutical
Henan Zhongjie Pharma
Qilu Pharma
Shanghai Xudong Haipu Pharmaceutical (SunRise)
Sine Pharma (Shanghai Pharma)
Warfarin Segment by Type
5mg/Tablet
3mg/Tablet
2.5mg/Tablet
1mg/Tablet
Others
Warfarin Segment by Application
Pulmonary Embolism (PE)
Mechanical Heart Valves (MHV) Replacement
Deep Vein Thrombosis (DVT)
Atrial Fibrillation (AF)
Others
Warfarin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Warfarin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Warfarin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Warfarin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Warfarin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Warfarin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Warfarin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Warfarin Market Size (2021-2032)
2.2.2 Global Warfarin Sales (2021-2032)
2.2.3 Global Warfarin Market Average Price (2021-2032)
2.3 Warfarin by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 5mg/Tablet
2.3.3 3mg/Tablet
2.3.4 2.5mg/Tablet
2.3.5 1mg/Tablet
2.3.6 Others
2.4 Warfarin by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Pulmonary Embolism (PE)
2.4.3 Mechanical Heart Valves (MHV) Replacement
2.4.4 Deep Vein Thrombosis (DVT)
2.4.5 Atrial Fibrillation (AF)
2.4.6 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Warfarin Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Warfarin Sales (Units) of Manufacturers (2021-2026)
3.3 Global Warfarin Revenue of Manufacturers (2021-2026)
3.4 Global Warfarin Average Price by Manufacturers (2021-2026)
3.5 Global Warfarin Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Warfarin, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Warfarin, Product Type & Application
3.8 Global Manufacturers of Warfarin, Established Date
3.9 Global Warfarin Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Amneal Pharma
4.1.1 Amneal Pharma Company Information
4.1.2 Amneal Pharma Business Overview
4.1.3 Amneal Pharma Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Amneal Pharma Warfarin Product Portfolio
4.1.5 Amneal Pharma Recent Developments
4.2 BRISTOL MYERS SQUIBB
4.2.1 BRISTOL MYERS SQUIBB Company Information
4.2.2 BRISTOL MYERS SQUIBB Business Overview
4.2.3 BRISTOL MYERS SQUIBB Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.2.4 BRISTOL MYERS SQUIBB Warfarin Product Portfolio
4.2.5 BRISTOL MYERS SQUIBB Recent Developments
4.3 Cipla (InvaGen)
4.3.1 Cipla (InvaGen) Company Information
4.3.2 Cipla (InvaGen) Business Overview
4.3.3 Cipla (InvaGen) Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Cipla (InvaGen) Warfarin Product Portfolio
4.3.5 Cipla (InvaGen) Recent Developments
4.4 IPCA LABS LTD
4.4.1 IPCA LABS LTD Company Information
4.4.2 IPCA LABS LTD Business Overview
4.4.3 IPCA LABS LTD Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.4.4 IPCA LABS LTD Warfarin Product Portfolio
4.4.5 IPCA LABS LTD Recent Developments
4.5 Orion Corporation Orion Pharma
4.5.1 Orion Corporation Orion Pharma Company Information
4.5.2 Orion Corporation Orion Pharma Business Overview
4.5.3 Orion Corporation Orion Pharma Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Orion Corporation Orion Pharma Warfarin Product Portfolio
4.5.5 Orion Corporation Orion Pharma Recent Developments
4.6 Taro Pharmaceutical Industries Ltd.
4.6.1 Taro Pharmaceutical Industries Ltd. Company Information
4.6.2 Taro Pharmaceutical Industries Ltd. Business Overview
4.6.3 Taro Pharmaceutical Industries Ltd. Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Taro Pharmaceutical Industries Ltd. Warfarin Product Portfolio
4.6.5 Taro Pharmaceutical Industries Ltd. Recent Developments
4.7 TEVA (Barr, PLIVA)
4.7.1 TEVA (Barr, PLIVA) Company Information
4.7.2 TEVA (Barr, PLIVA) Business Overview
4.7.3 TEVA (Barr, PLIVA) Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.7.4 TEVA (Barr, PLIVA) Warfarin Product Portfolio
4.7.5 TEVA (Barr, PLIVA) Recent Developments
4.8 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
4.8.1 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Company Information
4.8.2 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Business Overview
4.8.3 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.8.4 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Product Portfolio
4.8.5 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Recent Developments
4.9 Zydus Pharmaceuticals (USA) Inc
4.9.1 Zydus Pharmaceuticals (USA) Inc Company Information
4.9.2 Zydus Pharmaceuticals (USA) Inc Business Overview
4.9.3 Zydus Pharmaceuticals (USA) Inc Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Zydus Pharmaceuticals (USA) Inc Warfarin Product Portfolio
4.9.5 Zydus Pharmaceuticals (USA) Inc Recent Developments
4.10 Beijing Jialin Pharmaceutical
4.10.1 Beijing Jialin Pharmaceutical Company Information
4.10.2 Beijing Jialin Pharmaceutical Business Overview
4.10.3 Beijing Jialin Pharmaceutical Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Beijing Jialin Pharmaceutical Warfarin Product Portfolio
4.10.5 Beijing Jialin Pharmaceutical Recent Developments
4.11 Henan Zhongjie Pharma
4.11.1 Henan Zhongjie Pharma Company Information
4.11.2 Henan Zhongjie Pharma Business Overview
4.11.3 Henan Zhongjie Pharma Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Henan Zhongjie Pharma Warfarin Product Portfolio
4.11.5 Henan Zhongjie Pharma Recent Developments
4.12 Qilu Pharma
4.12.1 Qilu Pharma Company Information
4.12.2 Qilu Pharma Business Overview
4.12.3 Qilu Pharma Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Qilu Pharma Warfarin Product Portfolio
4.12.5 Qilu Pharma Recent Developments
4.13 Shanghai Xudong Haipu Pharmaceutical (SunRise)
4.13.1 Shanghai Xudong Haipu Pharmaceutical (SunRise) Company Information
4.13.2 Shanghai Xudong Haipu Pharmaceutical (SunRise) Business Overview
4.13.3 Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Product Portfolio
4.13.5 Shanghai Xudong Haipu Pharmaceutical (SunRise) Recent Developments
4.14 Sine Pharma (Shanghai Pharma)
4.14.1 Sine Pharma (Shanghai Pharma) Company Information
4.14.2 Sine Pharma (Shanghai Pharma) Business Overview
4.14.3 Sine Pharma (Shanghai Pharma) Warfarin Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Sine Pharma (Shanghai Pharma) Warfarin Product Portfolio
4.14.5 Sine Pharma (Shanghai Pharma) Recent Developments
5 Global Warfarin Market Scenario by Region
5.1 Global Warfarin Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Warfarin Sales by Region: 2021-2032
5.2.1 Global Warfarin Sales by Region: 2021-2026
5.2.2 Global Warfarin Sales by Region: 2027-2032
5.3 Global Warfarin Revenue by Region: 2021-2032
5.3.1 Global Warfarin Revenue by Region: 2021-2026
5.3.2 Global Warfarin Revenue by Region: 2027-2032
5.4 North America Warfarin Market Facts & Figures by Country
5.4.1 North America Warfarin Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Warfarin Sales by Country (2021-2032)
5.4.3 North America Warfarin Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Warfarin Market Facts & Figures by Country
5.5.1 Europe Warfarin Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Warfarin Sales by Country (2021-2032)
5.5.3 Europe Warfarin Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Warfarin Market Facts & Figures by Country
5.6.1 Asia Pacific Warfarin Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Warfarin Sales by Country (2021-2032)
5.6.3 Asia Pacific Warfarin Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Warfarin Market Facts & Figures by Country
5.7.1 South America Warfarin Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Warfarin Sales by Country (2021-2032)
5.7.3 South America Warfarin Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Warfarin Market Facts & Figures by Country
5.8.1 Middle East and Africa Warfarin Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Warfarin Sales by Country (2021-2032)
5.8.3 Middle East and Africa Warfarin Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Warfarin Sales by Type (2021-2032)
6.1.1 Global Warfarin Sales by Type (2021-2032) & (Units)
6.1.2 Global Warfarin Sales Market Share by Type (2021-2032)
6.2 Global Warfarin Revenue by Type (2021-2032)
6.2.1 Global Warfarin Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Warfarin Revenue Market Share by Type (2021-2032)
6.3 Global Warfarin Price by Type (2021-2032)
7 Segment by Application
7.1 Global Warfarin Sales by Application (2021-2032)
7.1.1 Global Warfarin Sales by Application (2021-2032) & (Units)
7.1.2 Global Warfarin Sales Market Share by Application (2021-2032)
7.2 Global Warfarin Revenue by Application (2021-2032)
7.2.1 Global Warfarin Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Warfarin Revenue Market Share by Application (2021-2032)
7.3 Global Warfarin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Warfarin Value Chain Analysis
8.1.1 Warfarin Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Warfarin Production Mode & Process
8.2 Warfarin Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Warfarin Distributors
8.2.3 Warfarin Customers
9 Global Warfarin Analyzing Market Dynamics
9.1 Warfarin Industry Trends
9.2 Warfarin Industry Drivers
9.3 Warfarin Industry Opportunities and Challenges
9.4 Warfarin Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Warfarin Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Warfarin Sales (Units) of Manufacturers (2021-2026)
Table 7. Global Warfarin Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Warfarin Revenue of Manufacturers (2021-2026)
Table 9. Global Warfarin Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Warfarin Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Warfarin Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Warfarin, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Warfarin, Product Type & Application
Table 14. Global Warfarin Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Warfarin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Amneal Pharma Company Information
Table 19. Amneal Pharma Business Overview
Table 20. Amneal Pharma Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Amneal Pharma Warfarin Product Portfolio
Table 22. Amneal Pharma Recent Developments
Table 23. BRISTOL MYERS SQUIBB Company Information
Table 24. BRISTOL MYERS SQUIBB Business Overview
Table 25. BRISTOL MYERS SQUIBB Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. BRISTOL MYERS SQUIBB Warfarin Product Portfolio
Table 27. BRISTOL MYERS SQUIBB Recent Developments
Table 28. Cipla (InvaGen) Company Information
Table 29. Cipla (InvaGen) Business Overview
Table 30. Cipla (InvaGen) Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Cipla (InvaGen) Warfarin Product Portfolio
Table 32. Cipla (InvaGen) Recent Developments
Table 33. IPCA LABS LTD Company Information
Table 34. IPCA LABS LTD Business Overview
Table 35. IPCA LABS LTD Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. IPCA LABS LTD Warfarin Product Portfolio
Table 37. IPCA LABS LTD Recent Developments
Table 38. Orion Corporation Orion Pharma Company Information
Table 39. Orion Corporation Orion Pharma Business Overview
Table 40. Orion Corporation Orion Pharma Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Orion Corporation Orion Pharma Warfarin Product Portfolio
Table 42. Orion Corporation Orion Pharma Recent Developments
Table 43. Taro Pharmaceutical Industries Ltd. Company Information
Table 44. Taro Pharmaceutical Industries Ltd. Business Overview
Table 45. Taro Pharmaceutical Industries Ltd. Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Taro Pharmaceutical Industries Ltd. Warfarin Product Portfolio
Table 47. Taro Pharmaceutical Industries Ltd. Recent Developments
Table 48. TEVA (Barr, PLIVA) Company Information
Table 49. TEVA (Barr, PLIVA) Business Overview
Table 50. TEVA (Barr, PLIVA) Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. TEVA (Barr, PLIVA) Warfarin Product Portfolio
Table 52. TEVA (Barr, PLIVA) Recent Developments
Table 53. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Company Information
Table 54. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Business Overview
Table 55. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Product Portfolio
Table 57. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Recent Developments
Table 58. Zydus Pharmaceuticals (USA) Inc Company Information
Table 59. Zydus Pharmaceuticals (USA) Inc Business Overview
Table 60. Zydus Pharmaceuticals (USA) Inc Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Zydus Pharmaceuticals (USA) Inc Warfarin Product Portfolio
Table 62. Zydus Pharmaceuticals (USA) Inc Recent Developments
Table 63. Beijing Jialin Pharmaceutical Company Information
Table 64. Beijing Jialin Pharmaceutical Business Overview
Table 65. Beijing Jialin Pharmaceutical Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Beijing Jialin Pharmaceutical Warfarin Product Portfolio
Table 67. Beijing Jialin Pharmaceutical Recent Developments
Table 68. Henan Zhongjie Pharma Company Information
Table 69. Henan Zhongjie Pharma Business Overview
Table 70. Henan Zhongjie Pharma Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Henan Zhongjie Pharma Warfarin Product Portfolio
Table 72. Henan Zhongjie Pharma Recent Developments
Table 73. Qilu Pharma Company Information
Table 74. Qilu Pharma Business Overview
Table 75. Qilu Pharma Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Qilu Pharma Warfarin Product Portfolio
Table 77. Qilu Pharma Recent Developments
Table 78. Shanghai Xudong Haipu Pharmaceutical (SunRise) Company Information
Table 79. Shanghai Xudong Haipu Pharmaceutical (SunRise) Business Overview
Table 80. Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Product Portfolio
Table 82. Shanghai Xudong Haipu Pharmaceutical (SunRise) Recent Developments
Table 83. Sine Pharma (Shanghai Pharma) Company Information
Table 84. Sine Pharma (Shanghai Pharma) Business Overview
Table 85. Sine Pharma (Shanghai Pharma) Warfarin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Sine Pharma (Shanghai Pharma) Warfarin Product Portfolio
Table 87. Sine Pharma (Shanghai Pharma) Recent Developments
Table 88. Global Warfarin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 89. Global Warfarin Sales by Region (2021-2026) & (Units)
Table 90. Global Warfarin Sales Market Share by Region (2021-2026)
Table 91. Global Warfarin Sales by Region (2027-2032) & (Units)
Table 92. Global Warfarin Sales Market Share by Region (2027-2032)
Table 93. Global Warfarin Revenue by Region (2021-2026) & (US$ Million)
Table 94. Global Warfarin Revenue Market Share by Region (2021-2026)
Table 95. Global Warfarin Revenue by Region (2027-2032) & (US$ Million)
Table 96. Global Warfarin Revenue Market Share by Region (2027-2032)
Table 97. North America Warfarin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 98. North America Warfarin Sales by Country (2021-2026) & (Units)
Table 99. North America Warfarin Sales by Country (2027-2032) & (Units)
Table 100. North America Warfarin Revenue by Country (2021-2026) & (US$ Million)
Table 101. North America Warfarin Revenue by Country (2027-2032) & (US$ Million)
Table 102. Europe Warfarin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 103. Europe Warfarin Sales by Country (2021-2026) & (Units)
Table 104. Europe Warfarin Sales by Country (2027-2032) & (Units)
Table 105. Europe Warfarin Revenue by Country (2021-2026) & (US$ Million)
Table 106. Europe Warfarin Revenue by Country (2027-2032) & (US$ Million)
Table 107. Asia Pacific Warfarin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 108. Asia Pacific Warfarin Sales by Country (2021-2026) & (Units)
Table 109. Asia Pacific Warfarin Sales by Country (2027-2032) & (Units)
Table 110. Asia Pacific Warfarin Revenue by Country (2021-2026) & (US$ Million)
Table 111. Asia Pacific Warfarin Revenue by Country (2027-2032) & (US$ Million)
Table 112. South America Warfarin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. South America Warfarin Sales by Country (2021-2026) & (Units)
Table 114. South America Warfarin Sales by Country (2027-2032) & (Units)
Table 115. South America Warfarin Revenue by Country (2021-2026) & (US$ Million)
Table 116. South America Warfarin Revenue by Country (2027-2032) & (US$ Million)
Table 117. Middle East and Africa Warfarin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Middle East and Africa Warfarin Sales by Country (2021-2026) & (Units)
Table 119. Middle East and Africa Warfarin Sales by Country (2027-2032) & (Units)
Table 120. Middle East and Africa Warfarin Revenue by Country (2021-2026) & (US$ Million)
Table 121. Middle East and Africa Warfarin Revenue by Country (2027-2032) & (US$ Million)
Table 122. Global Warfarin Sales by Type (2021-2026) & (Units)
Table 123. Global Warfarin Sales by Type (2027-2032) & (Units)
Table 124. Global Warfarin Sales Market Share by Type (2021-2026)
Table 125. Global Warfarin Sales Market Share by Type (2027-2032)
Table 126. Global Warfarin Revenue by Type (2021-2026) & (US$ Million)
Table 127. Global Warfarin Revenue by Type (2027-2032) & (US$ Million)
Table 128. Global Warfarin Revenue Market Share by Type (2021-2026)
Table 129. Global Warfarin Revenue Market Share by Type (2027-2032)
Table 130. Global Warfarin Price by Type (2021-2026) & (US$/Unit)
Table 131. Global Warfarin Price by Type (2027-2032) & (US$/Unit)
Table 132. Global Warfarin Sales by Application (2021-2026) & (Units)
Table 133. Global Warfarin Sales by Application (2027-2032) & (Units)
Table 134. Global Warfarin Sales Market Share by Application (2021-2026)
Table 135. Global Warfarin Sales Market Share by Application (2027-2032)
Table 136. Global Warfarin Revenue by Application (2021-2026) & (US$ Million)
Table 137. Global Warfarin Revenue by Application (2027-2032) & (US$ Million)
Table 138. Global Warfarin Revenue Market Share by Application (2021-2026)
Table 139. Global Warfarin Revenue Market Share by Application (2027-2032)
Table 140. Global Warfarin Price by Application (2021-2026) & (US$/Unit)
Table 141. Global Warfarin Price by Application (2027-2032) & (US$/Unit)
Table 142. Key Raw Materials
Table 143. Raw Materials Key Suppliers
Table 144. Warfarin Distributors List
Table 145. Warfarin Customers List
Table 146. Warfarin Industry Trends
Table 147. Warfarin Industry Drivers
Table 148. Warfarin Industry Restraints
Table 149. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Warfarin Product Image
Figure 5. Global Warfarin Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Warfarin Market Size (2021-2032) & (US$ Million)
Figure 7. Global Warfarin Sales (2021-2032) & (Units)
Figure 8. Global Warfarin Average Price (US$/Unit) & (2021-2032)
Figure 9. 5mg/Tablet Product Image
Figure 10. 3mg/Tablet Product Image
Figure 11. 2.5mg/Tablet Product Image
Figure 12. 1mg/Tablet Product Image
Figure 13. Others Product Image
Figure 14. Pulmonary Embolism (PE) Product Image
Figure 15. Mechanical Heart Valves (MHV) Replacement Product Image
Figure 16. Deep Vein Thrombosis (DVT) Product Image
Figure 17. Atrial Fibrillation (AF) Product Image
Figure 18. Others Product Image
Figure 19. Global Warfarin Revenue Share by Manufacturers in 2025
Figure 20. Global Manufacturers of Warfarin, Manufacturing Sites & Headquarters
Figure 21. Global Top 5 and 10 Warfarin Players Market Share by Revenue in 2025
Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. Global Warfarin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 24. Global Warfarin Sales by Region in 2025
Figure 25. Global Warfarin Revenue by Region in 2025
Figure 26. North America Warfarin Market Size by Country in 2025
Figure 27. North America Warfarin Sales Market Share by Country (2021-2032)
Figure 28. North America Warfarin Revenue Market Share by Country (2021-2032)
Figure 29. United States Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. Canada Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. Europe Warfarin Market Size by Country in 2025
Figure 32. Europe Warfarin Sales Market Share by Country (2021-2032)
Figure 33. Europe Warfarin Revenue Market Share by Country (2021-2032)
Figure 34. Germany Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. France Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. U.K. Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Italy Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Netherlands Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Asia Pacific Warfarin Market Size by Country in 2025
Figure 40. Asia Pacific Warfarin Sales Market Share by Country (2021-2032)
Figure 41. Asia Pacific Warfarin Revenue Market Share by Country (2021-2032)
Figure 42. China Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Japan Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. South Korea Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. India Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Australia Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. China Taiwan Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. South America Warfarin Market Size by Country in 2025
Figure 51. South America Warfarin Sales Market Share by Country (2021-2032)
Figure 52. South America Warfarin Revenue Market Share by Country (2021-2032)
Figure 53. Mexico Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Brazil Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Argentina Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Middle East and Africa Warfarin Market Size by Country in 2025
Figure 57. Middle East and Africa Warfarin Sales Market Share by Country (2021-2032)
Figure 58. Middle East and Africa Warfarin Revenue Market Share by Country (2021-2032)
Figure 59. Turkey Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. Saudi Arabia Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. UAE Warfarin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Global Warfarin Sales Market Share by Type (2021-2032)
Figure 63. Global Warfarin Revenue Market Share by Type (2021-2032)
Figure 64. Global Warfarin Price (US$/Unit) by Type (2021-2032)
Figure 65. Global Warfarin Sales Market Share by Application (2021-2032)
Figure 66. Global Warfarin Revenue Market Share by Application (2021-2032)
Figure 67. Global Warfarin Price (US$/Unit) by Application (2021-2032)
Figure 68. Warfarin Value Chain
Figure 69. Warfarin Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Warfarin Industry Opportunities and Challenges
提及公司
Amneal PharmaBRISTOL MYERS SQUIBBCipla (InvaGen)IPCA LABS LTDOrion Corporation Orion PharmaTaro Pharmaceutical Industries Ltd.TEVA (Barr, PLIVA)UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)Zydus Pharmaceuticals (USA) IncBeijing Jialin PharmaceuticalHenan Zhongjie PharmaQilu PharmaShanghai Xudong Haipu Pharmaceutical (SunRise)Sine Pharma (Shanghai Pharma)
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們